A sophisticated and physiologically relevant 3D model that recapitulates the patient tumor microenvironment.
BioDuro’s hTME-3DX Screen and Verify™ is a 2-step preclinical tumor testing platform to identify the most efficacious oncology drug candidates and potential patient populations. This technology is the first drug screening platform to combine humanized 3D cell culture and patient-derived xenograft models. Source
SCREEN with confidence: Ex vivo humanized 3D culture with 300 primary patient tumors
VERIFY for assurance: In vivo matched patient-derived xenograft models